| Brooten Medical Center | |
|
111 Pleasant Avenue Brooten MN 56316 | |
| (320) 346-2272 | |
| (320) 346-2273 |
| Full Name | Brooten Medical Center |
|---|---|
| Speciality | Family Medicine |
| Location | 111 Pleasant Avenue, Brooten, Minnesota |
| Authorized Official Name and Position | Kirk Stensrud (CEO) |
| Authorized Official Contact | 3206342208 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Brooten Medical Center 111 Pleasant Avenue P.o. Box 69 Brooten MN 56316 Ph: (320) 346-2272 | Brooten Medical Center 111 Pleasant Avenue Brooten MN 56316 Ph: (320) 346-2272 |
| NPI Number | 1255348223 |
|---|---|
| Provider Enumeration Date | 08/02/2006 |
| Last Update Date | 07/18/2012 |
| Medicare PECOS PAC ID | 5294789194 |
|---|---|
| Medicare Enrollment ID | O20050719000315 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255348223 | NPI | - | NPPES |
| 966011900 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Martin H Janning |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1396963922 PECOS PAC ID: 0749194991 Enrollment ID: I20031113000156 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Holly J Gibson |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1598752123 PECOS PAC ID: 8022915271 Enrollment ID: I20031216000327 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Gregory J Mohrenweiser |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1386797512 PECOS PAC ID: 8224001094 Enrollment ID: I20040818001363 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Joseph A Schneiderhan |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1003859786 PECOS PAC ID: 3870566540 Enrollment ID: I20040819000753 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Elizabeth A Ankeny |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154345759 PECOS PAC ID: 0042275422 Enrollment ID: I20041124000604 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Kevin W Peterson |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1912971581 PECOS PAC ID: 7719954270 Enrollment ID: I20050112000041 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Joseph M Klick |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1073516266 PECOS PAC ID: 4587611660 Enrollment ID: I20050331000782 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Michael J Holte |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1699788752 PECOS PAC ID: 1254370067 Enrollment ID: I20050502000366 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | John Andrew Dvorak |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1093755969 PECOS PAC ID: 2365423001 Enrollment ID: I20050601000887 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Rwanda D Campbell |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1174599641 PECOS PAC ID: 5799713129 Enrollment ID: I20050727001129 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Mark Janorschke |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1720055171 PECOS PAC ID: 1153388129 Enrollment ID: I20050907001063 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Gustave L Mellgren |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1871562926 PECOS PAC ID: 4082647615 Enrollment ID: I20050914001085 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Margie R Nelson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669572988 PECOS PAC ID: 7113948209 Enrollment ID: I20051216000405 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Billie J Grieve |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1598700882 PECOS PAC ID: 1254344575 Enrollment ID: I20060802000517 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Jessica M Vanderhagen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871501734 PECOS PAC ID: 1254335680 Enrollment ID: I20060828000045 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Noah N Chelliah |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1952485740 PECOS PAC ID: 9032166038 Enrollment ID: I20061205000606 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Sujatha Roberts |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1699899468 PECOS PAC ID: 6608976311 Enrollment ID: I20070711000088 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Vali Orandi |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1407955479 PECOS PAC ID: 4082601240 Enrollment ID: I20080729000679 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Robert P Montenegro |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1649284712 PECOS PAC ID: 1153499868 Enrollment ID: I20081008000474 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Nancy L Pesta Walsh |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1093982837 PECOS PAC ID: 8921166216 Enrollment ID: I20081014000765 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Jenna N Myrom |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1821242728 PECOS PAC ID: 1557427796 Enrollment ID: I20090312000641 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Matthew John Dammeyer |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1083838403 PECOS PAC ID: 8921177114 Enrollment ID: I20090826000426 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Joan M Lunzer |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1346253366 PECOS PAC ID: 5092617274 Enrollment ID: I20100318000781 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Matthew J Hamiel |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1205166493 PECOS PAC ID: 5799814265 Enrollment ID: I20100520000760 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | James Joyce |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1326017724 PECOS PAC ID: 4789713686 Enrollment ID: I20100602001070 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Matthew R Lee |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1326278573 PECOS PAC ID: 4082746391 Enrollment ID: I20100722000666 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | James E Matter |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1528167244 PECOS PAC ID: 5698676203 Enrollment ID: I20100913001142 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Duane Eric Westberg |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1578577656 PECOS PAC ID: 4688790496 Enrollment ID: I20100929001425 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Thomas John Haus |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1902810062 PECOS PAC ID: 4284750993 Enrollment ID: I20100929001602 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Scott R Maanum |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1992901086 PECOS PAC ID: 8820159460 Enrollment ID: I20101215001221 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Roderick Benjamin Brown |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1942214002 PECOS PAC ID: 6305026543 Enrollment ID: I20110205000028 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Annie M Molseed |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1619268067 PECOS PAC ID: 0143406066 Enrollment ID: I20110510000833 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Sophie Dojacques |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1669406542 PECOS PAC ID: 2961477229 Enrollment ID: I20110527000291 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Hamid R Abbasi |
|---|---|
| Provider Type | Practitioner - Neurosurgery |
| Provider Identifiers | NPI Number: 1932303526 PECOS PAC ID: 6507937588 Enrollment ID: I20120213000096 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Alissa J Redding |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1760614390 PECOS PAC ID: 5890970552 Enrollment ID: I20120928000404 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Thomas G Lewison |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1790034742 PECOS PAC ID: 3779733928 Enrollment ID: I20121024000110 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Robert E Citrowske Lee |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1770858474 PECOS PAC ID: 6709039795 Enrollment ID: I20121221000360 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Felix C Blanco |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1225385891 PECOS PAC ID: 8426201245 Enrollment ID: I20130103000339 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Robert B Kari |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1649693367 PECOS PAC ID: 0042441487 Enrollment ID: I20140327000897 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Erin R Dahlke |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1700028693 PECOS PAC ID: 2264754167 Enrollment ID: I20141203002729 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Kamran Khaghany |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1255502498 PECOS PAC ID: 6507917630 Enrollment ID: I20150114000608 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Dana Lyn Citrowske Lee |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1568868024 PECOS PAC ID: 7911223870 Enrollment ID: I20150311002708 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Justin L Towne |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1124133632 PECOS PAC ID: 3072830199 Enrollment ID: I20150327002229 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Kimberly A Versteeg |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1790763043 PECOS PAC ID: 5294723334 Enrollment ID: I20151120001417 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Jill M Zimmerman |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1730575861 PECOS PAC ID: 7416268339 Enrollment ID: I20160303000706 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Nicole M Zenk |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881056679 PECOS PAC ID: 0345548012 Enrollment ID: I20160413000316 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Jennifer Cavanagh |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1033213376 PECOS PAC ID: 3577665645 Enrollment ID: I20160829000892 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Brennen D Smith |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1376753277 PECOS PAC ID: 0749467280 Enrollment ID: I20160909002480 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Breann E Neiger |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1184902330 PECOS PAC ID: 6305133927 Enrollment ID: I20160926002166 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Robert L Fischer |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1336198696 PECOS PAC ID: 9234128828 Enrollment ID: I20171002001901 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Laura Davis Huggins |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1013335520 PECOS PAC ID: 9032337449 Enrollment ID: I20171004000053 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Tanya Marcy Freske |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558816561 PECOS PAC ID: 1153687033 Enrollment ID: I20171108003915 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Alisha Mae Colby-timm |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154770998 PECOS PAC ID: 8729344528 Enrollment ID: I20171110002231 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | William Lee Nyman |
|---|---|
| Provider Type | Practitioner - Diagnostic Radiology |
| Provider Identifiers | NPI Number: 1427096767 PECOS PAC ID: 3072589977 Enrollment ID: I20171220000851 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Kirsten G Crawford |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1992221907 PECOS PAC ID: 7517228026 Enrollment ID: I20180226001109 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Bailey A Dykema |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1942717046 PECOS PAC ID: 2769744069 Enrollment ID: I20180327000473 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Amy Lynn Brandt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750616348 PECOS PAC ID: 4284971870 Enrollment ID: I20190118002682 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Megan A Grimsley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1982181061 PECOS PAC ID: 6002153533 Enrollment ID: I20190122003430 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | David Edward Polzin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1427210533 PECOS PAC ID: 5890979314 Enrollment ID: I20190627001940 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Jessica Lynn Wilson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942889209 PECOS PAC ID: 5799194676 Enrollment ID: I20210505001035 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Nathan G Tiedeman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285083436 PECOS PAC ID: 1153613906 Enrollment ID: I20210505001615 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Micala Sue Danielson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003581935 PECOS PAC ID: 0749678555 Enrollment ID: I20211103000732 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Rebeka A Srbu |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1831753029 PECOS PAC ID: 5496130791 Enrollment ID: I20220922003619 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Tara Larson |
|---|---|
| Provider Type | Practitioner - Certified Registered Nurse Anesthetist (crna) |
| Provider Identifiers | NPI Number: 1184914160 PECOS PAC ID: 8426234501 Enrollment ID: I20221205002983 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Claire Fletcher |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1669976197 PECOS PAC ID: 8325420896 Enrollment ID: I20221227000601 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Kristi Mae Winter |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1578279337 PECOS PAC ID: 1456723543 Enrollment ID: I20230303001457 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
| Provider Name | Joshua Thomas |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1962940890 PECOS PAC ID: 2466722459 Enrollment ID: I20230807003607 |
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago
News Archive
InnaVirVax SA today announced the initiation of a Phase 2 clinical trial assessing the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy in the course of HIV-1 infection.
Until now immediate cooling of the newborn infant was the only treatment that could possibly prevent brain damage following oxygen deprivation during delivery. New research findings from the Sahlgrenska Academy at the University of Gothenburg and Sahlgrenska University Hospital, Sweden, in collaboration with Zhengzhou University in China, open up the possibility of a new and effective treatment that can be started as late as two days after birth.
An online training module has launched in the UK this week offering primary care healthcare professionals the opportunity to develop their knowledge and access resources to support patients with scarring.
Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.
› Verified 1 days ago